Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaElise A. Olsen, Jean Nichols, Madeleine Duvic et al.|Journal of Clinical Oncology|2001Cited by 610
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusDédée F. Murrell, Victoria P. Werth, Jean‐Claude Bystryn et al.|Journal of the American Academy of Dermatology|2008Cited by 586
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDédée F. Murrell, Pilar Iranzo, S.M. Peña et al.|Journal of the American Academy of Dermatology|2018Cited by 373